EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chronic Spontaneous Urticaria: Pathophysiological Mechanisms, Emerging Biomarkers, and Therapeutic Advances

Maykon Jhuly Martins de Paiva, Livia Cavalcante de Araújo, Maressa de Oliveira Marinho, Renata Ferreira Diogo de Paiva, Vitória Pires dos Santos Costa, Gabriela Pires Santomé de Faria, Guilherme Silva de Souza, Sávia Denise Silva Carlotto Herrera, Iangla Araújo de Melo Damasceno, Taides Tavares dos Santos, Juliane Farinelli Panontin, Walmirton Bezerra D’Alessandro

Allergies · 02.04.2026 · 6 (2) · 11

DOI: 10.3390/allergies6020011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergies, online erschienen am 02.04.2026. Verfasst von Maykon Jhuly Martins de Paiva und 11 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic urticaria (CU) is a mast cell-driven inflammatory skin disorder characterized by recurrent wheals, angioedema, or both lasting more than six weeks, often resulting in significant impairment of quality of life. Although CU has traditionally been regarded as a predominantly histamine-mediated condition, evidence accumulated over the past decade has redefined chronic spontaneous urticaria (CSU) as a complex immune-mediated disease with marked biological heterogeneity. Distinct pathogenic mechanisms involving autoimmune pathways, dysregulated mast cell activation, and chronic inflammatory networks have been identified, providing a mechanistic basis for disease persistence, variable severity, and therapeutic refractoriness. This review synthesizes current concepts in CSU pathophysiology, with emphasis on mast cell biology, autoimmune endotypes, and inflammatory amplification mechanisms. We further discuss emerging biomarkers with potential relevance for disease stratification and treatment prediction, as well as established and novel therapeutic strategies targeting key pathogenic pathways. By integrating mechanistic insights with clinical implications, this review highlights the transition toward endotype-driven and biomarker-guided management of chronic urticaria.

Zitieren

APA

Paiva, M. J. M. D., Araújo, L. C. D., Marinho, M. D. O., Paiva, R. F. D. D., Costa, V. P. D. S., Faria, G. P. S. D., Souza, G. S. D., Herrera, S. D. S. C., Damasceno, I. A. D. M., Santos, T. T. D., Panontin, J. F., & D’Alessandro, W. B. (2026). Chronic Spontaneous Urticaria: Pathophysiological Mechanisms, Emerging Biomarkers, and Therapeutic Advances. Allergies, 6(2), 11. https://doi.org/10.3390/allergies6020011

Vancouver

Paiva MJMD, Araújo LCD, Marinho MDO, Paiva RFDD, Costa VPDS, Faria GPSD, et al. Chronic Spontaneous Urticaria: Pathophysiological Mechanisms, Emerging Biomarkers, and Therapeutic Advances. Allergies. 2026;6(2):11. doi:10.3390/allergies6020011

BibTeX
@article{Paiva2026,
  author = {Paiva, Maykon Jhuly Martins de and Araújo, Livia Cavalcante de and Marinho, Maressa de Oliveira and Paiva, Renata Ferreira Diogo de and Costa, Vitória Pires dos Santos and Faria, Gabriela Pires Santomé de and Souza, Guilherme Silva de and Herrera, Sávia Denise Silva Carlotto and Damasceno, Iangla Araújo de Melo and Santos, Taides Tavares dos and Panontin, Juliane Farinelli and D’Alessandro, Walmirton Bezerra},
  title = {Chronic Spontaneous Urticaria: Pathophysiological Mechanisms, Emerging Biomarkers, and Therapeutic Advances},
  journal = {Allergies},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {11},
  doi = {10.3390/allergies6020011}
}
Kostenlos starten →